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A B S T R A C T
Symptoms of generalized anxiety disorder (GAD) are common among adolescents and can lead to severe psy-
chosocial impairment, yet there is a lack of a good quality scale to measure symptoms of generalized anxiety in
young people. The 7-item Generalized Anxiety Disorder Scale (GAD-7) is a self-report scale used to measure GAD
symptoms and has been validated in adult populations, but the measure's psychometric properties regarding
adolescents are unknown. The aim of this study was to investigate the reliability, factorial validity, and construct
validity of the GAD-7 in adolescents in a nationally representative sample from a general population. Our study
was based on Finnish survey data on 111,171 adolescents aged 14–18 years. Our results show that the GAD-7
demonstrates good psychometric properties in adolescents. The internal consistency of the GAD-7 was good
(Cronbach's α=0.91) and the instrument's unidimensional factor structure was supported. The associations of
GAD-7 sum scores with self-report measures of depression and social anxiety supported construct validity. The
psychometric properties of the GAD-7 in this sample of adolescents were similar to those reported among adults.
However, studies in which diagnostic interviews are performed are needed to demonstrate the diagnostic eﬃ-
cacy of the measure in this age group.
1. Introduction
The DSM-5 diagnostic criteria for generalized anxiety disorder
(GAD) include clearly excessive, uncontrollable, and often irrational
anxiety and worry of a duration of at least 6 months
(American Psychiatric Association, 2013). Worrying is often related to
everyday matters; in adolescents this can refer to, for example, school
performance, uncertain situations, or arriving on time to an event
(Wagner, 2001). The lifetime prevalence of GAD has been estimated to
be around 3.0% for females and 1.5% for males (Merikangas et al.,
2010). In the United States, 2.2% of adolescents meet the criteria for
GAD, and the prevalence rates show a modest but consistent increase
with age in adolescents aged 13–18 years (Costello et al., 2003;
Merikangas et al., 2010). Copeland et al. (2014), however, reported a
cumulative prevalence of GAD as high as almost 10% by young adult-
hood. One fourth of all lifetime cases of GAD start by age 20 years
(Kessler et al., 2005). Despite the fairly high prevalence and the psy-
chosocial impairment that can come with GAD, recognition of the
symptoms is relatively low, and GAD often remains both undetected
and undertreated (Kroenke et al., 2007; Lieb et al., 2005).
In children and adolescents, the most common symptoms of GAD
are feelings of tension, apprehension, need for reassurance, and irrit-
ability (Wagner, 2001). Unrecognized and untreated GAD in adoles-
cence can have long-term consequences and lead to, for example, poor
self-perceived health, high general impairment, and low quality of life
in adulthood (Wittchen et al., 2000). GAD in adolescents is often co-
morbid with depression and social phobia (Masi et al., 1999; Moﬃtt
et al., 2007; Ranta et al., 2009).
The 7-item Generalized Anxiety Disorder Scale (GAD-7) is a brief
self-report scale designed to identify probable cases of GAD
(Spitzer et al., 2006). It was developed as a screening tool for detecting
GAD in primary care patients and has become a widely used measure in
adults in many diﬀerent cultures (Delgadillo et al., 2012; Parkerson
et al., 2015). In primary care settings, the GAD-7 has been found to be
reliable and valid for adults, with a sensitivity of 89% and speciﬁcity of
82% at a cut-point of 10 points in clinical populations (Kroenke et al.,
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2007; Spitzer et al., 2006). This self-report measure has shown sig-
niﬁcant correlations with other anxiety scales (Beck Anxiety Inventory
[r=0.72] and the anxiety subscale of the Symptom Checklist-90
[r=0.74]) (Spitzer et al., 2006). It has been shown to correlate with
disability measures in primary care, and can be used to explore the level
of disability in patients with GAD (Ruiz et al., 2011).
The GAD-7 has been validated for the general adult population in a
nationally representative household survey conducted in Germany
(Löwe et al., 2008). Based on that data, the GAD-7 seems to be reliable,
unidimensional, and valid in measuring general anxiety in the general
population (Löwe et al., 2008). In a heterogeneous psychiatric sample,
the GAD-7 performed well as a measure of anxiety symptom severity,
but demonstrated poor speciﬁcity and a possible two-factor, not one-
factor, structure (Beard and Björgvinsson, 2014). However, the GAD-7
has mainly shown good sensitivity, speciﬁcity, reliability, and factorial,
construct, and concurrent validity in many speciﬁc subgroups, such as
patients with migraine (Seo and Park, 2015), drug and alcohol users
(Delgadillo et al., 2012), elderly people (Wild et al., 2014), and preg-
nant women (Zhong et al., 2015). The Portuguese version of the GAD-7
showed excellent psychometric properties and was found to be valid in
a Portuguese sample (Sousa et al., 2015). The Dutch web-based version
of the GAD-7 showed good reliability and validity in the general po-
pulation (Donker et al., 2011). In Finland, the GAD-7 has proven to be a
valid and useful tool for detecting GAD among adult high utilizers of
health care (Kujanpää et al., 2014).
Also, a systematic review and diagnostic meta-analysis has shown
that the GAD-7 has acceptable psychometric properties in adults
(Plummer et al., 2016). Whether the measure works as well and is in-
terpreted in a conceptually similar manner by respondents representing
diﬀerent age groups is still unknown. Although the GAD-7 has been
validated in adult population samples and primary care patients, its
psychometric properties in younger populations need to be examined
since diﬀerent age groups may not interpret the questionnaire in a si-
milar way. Research by Löwe et al. (2008) generated age- and gender-
speciﬁc normative data for the GAD-7 for diﬀerent age groups, in-
cluding those aged 14–24 years, and provided some evidence of the
unidimensionality of the scale in that age group. However, to the best of
our knowledge, there is no published research on the psychometric
properties of the GAD-7 in a general population sample of adolescents
only.
In this study we investigate the reliability, factorial validity, and
construct validity of the GAD-7 in adolescents (14−18 years old) in a
large and representative sample from the general population of Finland.
The speciﬁc aims were as follows:
1 To examine item characteristics, internal consistency, and factor
structure of the GAD-7 in a sample of adolescents.
2 To examine construct validity of the GAD-7 for adolescents by in-
vestigating associations between GAD-7 scores and self-report
measures of depression and social anxiety. To further examine the
psychometric properties of the GAD-7 we also present ﬁndings on
the convergent and discriminant validity of the GAD-7 in subgroups
deﬁned by sex and age.
Construct validity can be conceptualized to consist of both con-
vergent and discriminant validity. We use the term convergent validity
to refer to the strength of association between the GAD-7 and a measure
of social anxiety, given the fear and physiological arousal-related fac-
tors shared in common by the diﬀerent anxiety disorders. Although
generalized anxiety and depression also have in common certain un-
derlying factors, they are diﬀerentiated by the underlying factors of
hyperarousal (in anxiety) versus low positive mood (in depression).
Thus, we use the term discriminant validity to refer to the strength of
association between the GAD-7 and a measure of depression. For a full
discussion of the constructs, see Cummings et al. (2014).
We expected that our analyses of data from our sample of Finnish
adolescents would show the internal consistency of the GAD-7 to be
good and for the unifactorial model to be supported. In examining sex
and age diﬀerences in the GAD-7 scores we expected females to have
higher scores since anxiety disorders and symptoms are more common
among females than males of this age (Lewinsohn et al., 1998;
Merikangas et al., 2010). We also expected to ﬁnd an increase in GAD-7
scores with age in adolescents aged 14–18, with the youngest group
having the lowest scores and the oldest group the highest scores.
2. Material and methods
2.1. Subjects and procedure
The School Health Promotion Study (SHPS) of the National Institute
for Health and Welfare is a survey conducted among students aged
mainly 14–18 years. The data include students from both compulsory
basic comprehensive school in grades 8 and 9, and from noncompulsory
secondary education. The latter in Finland encompasses academic
education, referred to as upper secondary school (USS), and vocational
education or vocational school (VS). Among the students in the study,
8th and 9th graders in basic comprehensive school were mostly aged
14–16 years old, and 1st and 2nd year students in secondary education
(both USS and VS) were mostly aged 16–18.
The SHPS is conducted every second year, with the purpose being to
examine the health, well-being, and behavior of adolescents. Every
municipality in Finland is approached and decides if the schools in the
area will participate. Students complete the questionnaire in-
dependently and anonymously during a school lesson (45 min) under
the supervision of a teacher.
The data used in the current study were collected in April and May
2015. Most of the data were collected online but students in some basic
comprehensive schools completed paper surveys with the same ques-
tions. Altogether 120,100 adolescents participated (58,078 males and
62,022 females). This number covers 64% of all 8th and 9th graders and
43% of all USS students in Finland (National Institute for Health and
Welfare, 2016).
Of the SHPS respondents who reported their age, those who were
aged 14–18 years were included in the current study (110,392 ado-
lescents). In addition to that, there were 6676 respondents who did not
report their age. For them, age was estimated as the mean of the age of
all the students in the same grade (8th graders, 9th graders, ﬁrst year
USS students, second year USS students, ﬁrst year VS students, and
second year VS students, respectively 14.86, 15.86, 16.85, 17.87,
17.24, and 18.04). These adolescents were also included in the study.
Thus, there were altogether 117,068 adolescents included.
Of the 14- to18-year old study subjects 5897 (5.04%) were excluded
from this study because of missing data (at least one missing value for
the 7 questions of the GAD-7, the 3 social phobia questions, or the 2
depression questions). In comparison to subjects without missing data,
a one-way analysis of variance showed that the excluded cases had si-
milar distributions by sex (p= .060) and age (p= .152). Our ﬁnal
sample for analysis included 111,171 adolescents aged 14–18 years.
2.2. Measurements
2.2.1. The GAD-7
The seven items of the GAD-7 ask respondents to indicate how often,
over the past 2 weeks, they have been bothered by each of the seven
core symptoms of GAD that are presented in Table 2 (Spitzer et al.,
2006). The answers are rated on a 4-point scale as 0 (not at all), 1
(several days), 2 (more than half the days), and 3 (nearly every day)
(Spitzer et al., 2006). Therefore, GAD-7 sum scores range from 0 to 21.
A sum score of at least 10 points is the cut-oﬀ point most often taken to
reﬂect at least moderate generalized anxiety (Spitzer et al., 2006). A
total score of 15 or more on the GAD-7 represents severe anxiety
symptoms (Spitzer et al., 2006). In the SHPS a Finnish translation of the
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GAD-7 was used. The translation was undertaken by Finnish psychiatry
professionals and has been evaluated as valid for screening for general
anxiety among Finnish-speaking people, at least in primary health care
(Kujanpää et al., 2014).
2.2.2. The Mini-Social Phobia Inventory
The SHPS respondents completed the Mini-Social Phobia Inventory
(Mini-SPIN), a measure of social anxiety disorder (Connor et al., 2001).
In the Mini-SPIN, respondents are asked how much, during the past
week, they have been bothered by three symptoms of social anxiety: (1)
"Fear of embarrassment causes me to avoid doing things or speaking to
people," (2) "I avoid activities in which I am the center of attention,"
and (3) "Being embarrassed or looking stupid are among my worst
fears" (Connor et al., 2001). The answers are rated on a 5-point scale as
0 (not at all), 1 (a little bit), 2 (somewhat), 3 (very much), or 4 (ex-
tremely). The Mini-SPIN has demonstrated good psychometrics for
screening for social anxiety disorder in adolescents from the general
population (Ranta et al., 2012). The cut-oﬀ point was set at 6 points as
this score has been found to have the best diagnostic eﬃciency,
meaning it is the optimal cut-oﬀ to use both to identify and rule out the
presence of social anxiety disorder (Ranta et al., 2012).
2.2.3. Depression
As an indicator of depression, the survey included a two-item de-
pression module with questions (1) “During the past MONTH, have you
OFTEN been bothered by feeling down, depressed or hopeless?” and (2)
“During the past MONTH, have you OFTEN been bothered by little
interest or pleasure in doing things?” These questions detect most cases
of depression and have reasonable validity as a case-ﬁnding instrument
(Arroll et al., 2003; Whooley et al., 1997). A positive response to either
of the two questions has in previous research been shown to have a
sensitivity of 96% and a speciﬁcity of 57% (Whooley et al., 1997). In
this study, a “yes” answer to both of the two questions was considered a
possible case of depression, and the depression variable was scored as
dichotomous.
2.3. Statistical analyses
Mean scores, item-intercorrelations (Spearman's ρ), and corrected
item-total correlations (Spearman's ρ between the respective item and
the total score without the respective item) were calculated to in-
vestigate item characteristics of the GAD-7. For reliability the internal
consistency of the GAD-7 was tested using Cronbach's Alpha. The in-
ternal consistency was assessed for the total adolescent population
sample, and independently for males and for females, for each of the
ﬁve diﬀerent age groups, and for four subgroups based on estimates for
the presence and absence of both social anxiety and depression.
The factor structure of the GAD-7 was examined using conﬁrmatory
factor analysis (CFA). The unidimensionality of the GAD-7, suggested
by a number of studies (Dear et al., 2011; Löwe et al., 2008; Mills et al.,
2014; Ryan et al., 2013; Sawaya et al., 2016), was assessed with CFA. In
the CFA we used diagonally weighted least squares as this method is
designed for ordinal data, is less biased, and is more accurate than the
maximum likelihood method (Li, 2016). To assess how well the one-
factor CFA model ﬁtted the data, ﬁve diﬀerent criteria were used. The
root mean square error of approximation and the comparative ﬁt index
were used to assess whether the model was adequate (Browne and
Cudeck, 1993; Hu and Bentler, 1999). The relative ﬁt of the model was
measured by the comparative ﬁt index and the Tucker Lewis index. The
ﬁt between the hypothesized model and the observed covariance matrix
was assessed based on the goodness of ﬁt index (GFI) and the adjusted
goodness of ﬁt index (AGFI).
We examined GAD-7 scale associations with the Mini-SPIN and with
the two-item depression module. We also investigated associations of
the GAD-7 scores with sex and age. Partial eta squared (ηp²) was used
for measuring eﬀect sizes.
3. Results
3.1. Characteristics of the sample
The characteristics of our sample are summarized in Table 1. Our
sample included 37.5% of all the Finnish adolescents aged 14–18
(Oﬃcial Statistics of Finland, 2016). The mean age of the adolescents in
our sample was 16.49 years (SD=1.16 years). Among them, 11.59%
(5.90% of males and 19.93% of females) had a GAD-7 total score of at
least 10 points, the cut-point most often used to indicate moderate le-
vels of the symptoms of generalized anxiety. In our study sample,
4.57% of all adolescents (2.30% of males and 6.70% of females) had a
total score of at least 15, the cut-point for severe levels of anxiety
symptoms.
3.2. Item characteristics, internal consistency, and factor structure
Descriptive characteristics for the individual GAD-7 items are
summarized in Table 2, and for the whole scale in Table 3. Mean item
scores ranged from 0.45 to 0.72. Corrected item-total correlations were
ρ=0.56 or greater, and intercorrelations between the GAD-7 items
ranged from ρ=0.42 to ρ=0.72. The mean score of the total GAD-7
was 3.94 (SD=4.67). The internal consistency of the GAD-7 was good
in the total sample (α=0.91) and in all the subgroups, with Cronbach's
alpha ranging from 0.90 to 0.92 in the age and sex subgroups.
The one-factor structure of the GAD-7 was supported by the CFA. All
seven items were speciﬁed as indicators of a single factor. Table 2
Table 1
Characteristics of the study sample (n=111,171).
Sex ratio
% Male/female
(%)
Age, M Age, SD
Total sample 48.4/51.6 16.49 1.16
Sex
Male 48.43 16.48 1.16
Female 51.57 16.50 1.16
Age in years
14 14.46 49.4/50.6 14.68 0.20
15 20.84 49.0/51.0 15.52 0.30
16 25.75 47.9/52.1 16.51 0.28
17 27.72 48.3/51.7 17.45 0.29
18 11.23 47.7/52.3 18.23 0.24
Social anxiety
No social anxiety (Mini-SPIN<6) 78.49 51.7/48.3 16.49 1.16
Social anxiety (Mini-SPIN≥ 6) 21.51 36.6/63.4 16.51 1.15
Depression
No depression (depression
sum<2)
78.06 52.5/47.5 16.49 1.16
Depression (depression sum=2) 21.94 33.9/66.1 16.51 1.16
Table 2
Characteristics of the GAD-7 items in the adolescent sample (n = 111,171).
Corrected CFAa
Item-total factor
No. Item M SD Correlation loading
1 Feeling nervous, anxious, or on edge 0.68 0.84 0.72 0.87
2 Not being able to stop or control
worrying
0.45 0.78 0.70 0.94
3 Worrying too much about diﬀerent
things
0.60 0.83 0.71 0.91
4 Trouble relaxing 0.55 0.82 0.68 0.86
5 Being so restless that it is hard to sit
still
0.48 0.79 0.56 0.75
6 Becoming easily annoyed or irritable 0.72 0.88 0.68 0.81
7 Feeling afraid as if something awful
might happen
0.46 0.82 0.57 0.77
a Conﬁrmatory factor analysis.
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shows the loadings of the seven items on the single factor, with loading
values ranging from γ=0.73 to γ=0.94. In the CFA, the unidimen-
sional model ﬁtted the data quite well. The relative ﬁt of the model,
measured by the comparative ﬁt index (0.990) and the Tucker Lewis
index (0.986), was very good. Absolute ﬁt of the model, measured by
the scaled root mean square error of approximation (0.096; 90% CI:
0.095−0.097), was less than ideal. However, based on both
GFI= 0.999 and AGFI= 0.996, the ﬁt between the hypothesized
model and the observed covariance matrix was good.
3.3. Construct validity and subgroup diﬀerences
Increasing scores on the GAD-7 scale were strongly associated with
both the Mini-SPIN inventory and the evaluation of depression. The
intercorrelation (Pearson's) between the GAD-7 sum score and the Mini-
SPIN sum score was r=0.46. The intercorrelation (Spearman's) be-
tween the GAD-7 sum score and the dichotomous depression variable
was ρ=0.50.
Table 3 shows the association between the GAD-7 sum scores and
being in one of the examined subgroups. The subgroup with social
anxiety and the subgroup with depression had signiﬁcantly higher
scores than did the subgroups without these comorbidities. There were
modest diﬀerences in the sum scores between age subgroups as well,
with the youngest subgroup having the lowest scores and the oldest
subgroup the highest scores, with an eﬀect size of ηp²= 0.003. How-
ever, there did not seem to be a linear correlation between the GAD-7
total score and age, the intercorrelation being r=0.044.
4. Discussion
In this study we found evidence that the GAD-7 is a reliable self-
report measure with good psychometric properties in Finnish adoles-
cents. In keeping with earlier ﬁndings on adults, the unidimensional
structure of the GAD-7 was supported by the results from CFA. We did
not ﬁnd a linear association between the GAD-7 sum score and age,
although scores for the youngest age group (i.e., 14-year-olds) were
lower than those of the oldest age group. In accordance with our hy-
potheses, females had signiﬁcantly higher GAD-7 scores than did males.
In addition to that, the associations of the GAD-7 sum score with self-
report measures of depression and social anxiety supported the con-
struct validity of the GAD-7. In a German general population study, the
intercorrelation between the GAD-7 and the PHQ-2 depression scale in
adults was r=0.64 (Löwe et al., 2008). Our ﬁnding was fairly similar
to that (0.50).
The psychometric properties of the GAD-7 in this population sample
of Finnish adolescents were essentially similar to those reported among
adults from various countries. The internal consistency of the GAD-7
has usually been reported in terms of Cronbach's alpha, ranging from
about 0.80–0.91 for diﬀerent groups (Delgadillo et al., 2012; Donker
et al., 2011; Parkerson et al., 2015; Sousa et al., 2015; Spitzer et al.,
2006; Wild et al., 2014; Zhong et al., 2015). In this research, Cronbach's
alpha was at least 0.90 for the total sample, for males, for females, and
for all age groups. The internal consistency of the GAD-7 was thus
supported among adolescents as well.
The anxiety symptoms described in the GAD-7 seemed to be
somewhat more prevalent in our sample of adolescents than in adult
general populations. Wong et al. (2014) reported a mean GAD-7 sum
score of 4.6 (SD=4.6) in a general population sample of Australian
adolescents aged between 14 and 16 years (n=976). These scores are
similar to those found in our study.
In a German general population sample of those aged 14 years or
older, the GAD sum score mean was found to be 2.95 (SD=3.41)
(Löwe et al., 2008). The clearest diﬀerences between the mean scores of
the German adult sample and in our study were for the items "Becoming
easily annoyed or irritable" (M=0.46 and M=0.72, respectively) and
"Feeling nervous, anxious, or on edge" (M=0.50 and M=0.68, re-
spectively), which were also the most often reported symptoms in our
adolescent sample. The high frequency of these symptoms in adoles-
cents may be related to the fact that irritability is common in adoles-
cence (Stringaris, 2011). The distribution of anxiety symptoms and si-
tuations that are related to worrying may be diﬀerent for adolescents
compared to an adult population. However, whether these diﬀerences
in results are due to diﬀerent measurement error rates in the GAD-7
across age groups rather than to actual diﬀerences in the prevalence of
speciﬁc GAD symptoms remains unknown.
In this study the convergent validity for the GAD-7 (i.e., the strength
of association with the Mini-SPIN) was high, but it was slightly lower
than for discriminant validity (the strength of association with the de-
pression measure). Although at ﬁrst glance these ﬁndings might appear
even to suggest a lack of construct validity for the GAD-7, they do
concur with other researchers’ ﬁndings of a very strong association
between symptoms of generalized anxiety and depression among ado-
lescents (Moﬃtt et al., 2007), and ﬁndings that diﬀerent types of an-
xiety (i.e., generalized and social anxiety) may share diﬀerent under-
lying, common factors with depression (Cummings et al., 2014). As
whole, high correlations between the GAD-7 and the depression mea-
sure, as well as between the GAD-7 and the Mini-SPIN as found in the
present study, are consistent with empirical ﬁndings of high co-
morbidity between generalized anxiety symptoms and both depression
and social anxiety (Moﬃtt et al., 2007; Ranta et al., 2009). Further-
more, these ﬁndings can be interpreted to reﬂect the complex associa-
tions between diﬀerent types of anxiety and depression in youth: on the
basis of prior research correlations of GAD symptoms with symptoms of
social anxiety need not to be higher than the correlations between GAD
symptoms and depression symptoms merely due to the group labels
attached to the main categories of symptoms (i.e., anxiety-related
symptoms vs. depression-related symptoms; see Cummings et al.,
2014).
An essential strength of this study was a uniquely large sample that
was population based and included more than a third (37.5%) of all the
Finnish adolescents aged 14–18 years. In a Finnish methodological
analysis of the present sample, done by the National Institute for Health
and Welfare (Halme et al., 2016), the data were evaluated to be of high
quality and representative of the Finnish adolescent population. To our
knowledge, this is the ﬁrst study that has examined the psychometrics
of the GAD-7 in an exclusively adolescent sample and this study has the
highest number of participants in any validation research done on the
GAD-7. This kind of national data oﬀers a good opportunity to make a
Table 3
Internal consistency and GAD-7 sum scores by subgroups.
GAD-7 total
score
Cronbach's Eﬀect
Alpha M SD size (ηp²)
Total sample 0.91 3.94 4.67
Sex 0.082
Male 0.91 2.56 3.89
Female 0.90 5.23 4.96
Age in years 0.003
14 0.90 3.35 4.46
15 0.92 4.04 4.84
16 0.91 3.97 4.69
17 0.91 4.01 4.60
18 0.91 4.25 4.69
Social anxiety 0.147
No social anxiety (Mini-
SPIN<6)
0.89 3.00 3.83
Social anxiety (Mini-SPIN≥ 6) 0.91 7.35 5.74
Depression 0.295
No depression (depression
sum<2)
0.86 2.59 3.29
Depression (depression
sum=2)
0.90 8.72 5.61
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cross-sectional assessment of the diﬀerent aspects of self-reported an-
xiety. However, the generalizability of the study results to other
countries and other ethnic groups is unknown. Caution should be
warranted especially when generalizing the ﬁndings of this study to
non-Western populations (Parkerson et al., 2015).
A central limitation of this study was the lack of diagnosis-speciﬁc
criterion measures (i.e., assessment of GAD and other anxiety/aﬀective
disorders) to assess the criterion validity of the GAD-7. Since structured
diagnostic interviews were not conducted, validity analyses were lim-
ited and based on self-report only. Nevertheless, the results from this
study correspond well with results from earlier analyses of primary care
patients and adult populations. Therefore, there is some evidence sup-
porting the conclusion that the GAD-7 may be a valid self-report anxiety
measure for adolescent subjects. Nonlinear associations between age
and generalized anxiety symptoms in mid-adolescence warrant further
study.
The GAD-7 has already been found to have acceptable properties for
identifying GAD in adults. It is an important step in validating the
measure to demonstrate its measurement properties in adolescents as
well. Our research shows promising results regarding the psychometrics
of the GAD-7 in adolescents, as this instrument seemed to be a reliable
and valid measure in terms of our sample. However, more evidence is
needed to assess the accuracy of the questionnaire for use in identifying
GAD. This would call for a representative sample to be administered
structured interviews that enable diagnostic eﬃciency statistics to be
developed for the instrument. Further adolescent studies are required to
evaluate the GAD-7 in detail in clinical and nonclinical settings.
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